Central Florida Optical is categorized under Kidney Dialysis Centers in Orlando, FL .
Central Florida Optical was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 8114902 by the NAICS.
If you are seeking more information, feel free to contact Gerry Burtis, Manager at the company’s single location by writing to 1900 North Orange Avenue, Orlando, Florida FL 32804 or by phoning (407) 860-0214. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Florida Optical |
| Contact Person: | Gerry Burtis, Manager |
| Address: | 1900 North Orange Avenue, Orlando, Florida 32804 |
| Phone Number: | (407) 860-0214 |
| Website Address: | mosestaylorhospital.net |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Kidney Dialysis Centers |
| SIC Code: | 8092 |
| NAICS Code: | 8114902 |
| Share This Business: |
Central Florida Optical was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 8114902. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Gerry Burtis, Manager for inquiries that concern Central Florida Optical by calling the company number (407) 860-0214, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Florida Optical can be found at the coordinates 28.56889,-81.37276 as well as the street address 1900 North Orange Avenue in Orlando, Florida 32804.
For its online presence, you may visit Central Florida Optical’s website at mosestaylorhospital.net and engage with its social media outlets through on Twitter and on Facebook.